Cationic polyethers and polyesters for enhanced biodegradability and performance
Innovative cationic polyether and polyester platforms designed for improved biodegradability and performance in active delivery and deposition applications. Developed using scalable production methods, these polymers offer potential for industrial use with environmental benefits.
Overview
The University of Florida presents two innovative polymer platforms: cationic polyethers and polyesters, poised to enhance performance and environmental sustainability in various applications. These polymers are engineered to offer improved biodegradability while retaining compatibility with existing production technologies, making them ideal for industries focused on sustainable solutions. The polyether platform is created through bulk copolymerization, while the polyester platform utilizes reactive extrusion, ensuring industrial feasibility.
Technical specifications
- Polyether Platform: Developed via bulk copolymerization of ethylene oxide with subsequent conversion to cationic groups using click chemistry.
- Polyester Platform: Created through reactive extrusion of commercial resins like polylactide, with peroxide-initiated grafting for covalent attachment of cationic groups.
- Biodegradability: Polyethers and polyesters designed for biodegradability in various environments with mechanisms involving common enzymatic actions.
- Applications: Effective in coacervation/adsorption behavior and active deposition/delivery.
- Testing: Includes biodegradation rates and extents via respirometry, phase behavior mapping, and adsorption experiments on substrates such as silicone and textiles.
Technology readiness level
This technology is currently at TRL 3, indicating that it is in the early stages of experimental proof of concept. Ongoing developments will focus on aligning with commercial benchmarks and further validation with industry partners.
About University of Florida
The University of Florida is a comprehensive public research university with a broad academic and research portfolio and a statewide presence. Industry collaborates through co-located labs and shared core facilities and through an integrated academic health system that accelerates clinical translation. A statewide extension network and multiple research and education sites connect companies with field-scale testing and rapid deployment, while incubators and an adjacent innovation district provide pathways from lab to market. Research is supported by competitive funding from major federal agencies such as NIH, NSF, USDA, and DOE. A dedicated technology transfer office supports IP, licensing, and startup formation.
delivered to your inbox.